Abstract
Intrathecal drug delivery systems (IDDS) are commonly utilized for many refractory chronic pain conditions and cancer associated pain. Manufacturer recommendations are available for physicians and MRI facilities to review prior to obtaining a scan1. We discuss a case in which IDDS malfunction occurred following MRI, despite following manufacturer instructions prior to and after MRI, resulting in profound medication overdose.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
